Sfoglia per Autore
Identification of a new molecule with readthrough activity to rescue CFTR protein function
CHA on CDK2: a way to identify the best pharmacophore model for the virtual screening of new inhibitors
Investigation on MMACHC-R161Q pathological mutant from cblC disease
INVESTIGATION ON MMACHC-R161Q PATHOLOGICAL MUTANT FROM cblC DISEASE, A RARE METABOLIC DISORDER OF VITAMIN B12 METABOLISM
Lisa Longo; Rita Carrotta; Maria Assunta Costa; Rosa Passantino; Maria Rosalia Mangione; Loredana Randazzo; Maria Grazia Ortore; Michela Bollati; Matteo De Rosa; Mario Milani; Adrian Velazquez Campoy; Marco Tutone; Vincenzo Martorana; Silvia Vilasi
Derivati Ossadiazolici per il trattamento della fibrosi cistica: Readthrough di mutazioni nonsense
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell.
Manuela Labbozzetta; Monica Notarbartolo; Maurizio Sajeva; Marco Tutone; Paola Poma
Rescuing CFTR Protein Function: 1,3,4-oxadiazoles versus 1,2,4-oxadiazoles as readthrough inducing drugs
Ivana Pibiri, Laura Lentini, Raffaella Melfi, Marco Tutone, Sara Baldassano, Aldo Di Leonardo, Andrea Pace
Unlocking Cellular Secrets: Charting Proteomic Frontiers in LRBA Deficiency Through the Lens of Readthrough Promoters
I. Fiduccia, D. Ricci, F. Corrao, E. Vitale, R. Melfi, A. Pace, M. Tutone, M.G. Zizzo, L. Lentini, I. Pibiri, Michel Moutschen, Samuel Meier-Menches
Translational Readthrough Inducing Drugs (TRIDs): a study of biodistribution evaluation in mice models
I. Fiduccia, F. Corrao, R. Perriera, A. Di Leonardo, R. Melfi, A. Pace, M. Tutone, M.G. Zizzo, L. Lentini, I. Pibiri
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile